| Pharmaceutical active ingredients: |
| Drofenine HydrochloridePropyphenazone |
| Available forms, composition and doses of Spasmo-Cibalgine: |
| N / A |
| Spasmo-Cibalgine medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB54 - Propyphenazone, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Spasmo-Cibalgin | Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgin Comp | Codeine Phosphate; Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgin Compositum S | Codeine Phosphate; Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgin S | Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgina | Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmocin | Scopolamine Butylbromide | Geofman Pharmaceuticals; Sahar Internationl Trading |
| Spasmocip | Acetaminophen; Dextropropoxyphene | Cipla |
| Spasmocip Plus | Acetaminophen; Dextropropoxyphene; Dicyclomine Hydrochloride | Cipla |
| Spasmocol | Alverine Dihydrogen Citrate; Sterculia | Norgine |
| Spasmocor | Benzyl Mandelate; Nitroglycerin; Pentaerithrityl Tetranitrate; Vitamin B3 (Nicotinic Acid) | Asta Medica; Viatris |